NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1Social Media CoordinatorApr 121 min readCheck out this new event and grab a seat! REGISTER
NEW Event ~ A first-line treatment option for adults with anemia due to lower-risk MDS ~ 11/13/25 @ Capital Grille
Comments